Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Historical Holders from Q3 2016 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
ADPT on Nasdaq
Shares outstanding
151,865,218
Price per share
$16.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
145,445,972
Total reported value
$2,175,466,292
% of total 13F portfolios
0%
Share change
-2,761,664
Value change
-$14,778,534
Number of holders
268
Price from insider filings
$16.24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.7% $78,532,683 9,940,846 BlackRock, Inc. 31 Mar 2025
Sumitomo Mitsui Trust Group, Inc. 4.6% $53,981,782 6,833,137 Sumitomo Mitsui Trust Group, Inc. 31 Dec 2024
Nikko Asset Management Americas, Inc. 4.6% $53,981,782 6,833,137 Nikko Asset Management Americas, Inc. 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 4.3% $49,711,809 6,292,634 Millennium Management LLC 31 Dec 2024
Rubric Capital Management LP 4.1% $72,889,139 6,256,847 Rubric Capital Management LP 30 Jun 2025
ARK Investment Management LLC 2.9% -27% $40,863,635 -$15,506,311 4,398,669 -28% ARK Investment Management LLC 31 May 2025
As of 30 Sep 2025, Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 268 institutional shareholders filing 13F forms. They hold 145,445,972 shares. of 151,865,218 outstanding shares (96%) .

Top 25 institutional shareholders own 71% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VIKING GLOBAL INVESTORS LP 20% 29,993,708 0% 1.2% $448,705,872
BlackRock, Inc. 8.8% 13,357,977 -2.3% 0% $199,835,344
VANGUARD GROUP INC 7.4% 11,275,169 -0.04% 0% $168,676,528
AMERIPRISE FINANCIAL INC 3.9% 5,971,706 +84% 0.02% $89,336,731
Amova Asset Management Americas, Inc. 2.4% 3,650,646 -15% 0.53% $54,650,171
Sumitomo Mitsui Trust Group, Inc. 2.4% 3,650,646 -15% 0.03% $54,613,664
GEODE CAPITAL MANAGEMENT, LLC 2.2% 3,401,030 +5.8% 0% $50,885,690
ARK Investment Management LLC 2.1% 3,165,636 -21% 0.28% $47,357,912
Aristotle Atlantic Partners, LLC 2.1% 3,126,719 +8.6% 1.4% $46,775,716
STATE STREET CORP 2% 3,079,282 +1.7% 0% $46,066,059
Driehaus Capital Management LLC 2% 3,019,940 +25% 0.32% $45,178,302
FRED ALGER MANAGEMENT, LLC 1.7% 2,514,234 +6.7% 0.15% $37,612,941
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.6% 2,441,402 +544% 0.02% $36,523,374
Blue Water Life Science Advisors, LP 1.4% 2,145,145 0% 29% $32,091,369
MACQUARIE GROUP LTD 1.4% 2,104,414 +219% 0.04% $31,482,000
GOLDMAN SACHS GROUP INC 1.2% 1,879,852 -2.5% 0% $28,122,586
Iron Triangle Partners LP 1.2% 1,820,915 +22% 3.9% $27,240,888
DEUTSCHE BANK AG\ 1.1% 1,713,139 +905% 0.01% $25,628,559
BANK OF AMERICA CORP /DE/ 1.1% 1,597,999 -14% 0% $23,906,066
DIMENSIONAL FUND ADVISORS LP 0.91% 1,386,363 -0.24% 0% $20,730,107
JENNISON ASSOCIATES LLC 0.86% 1,311,487 +1269% 0.01% $19,619,844
Voya Investment Management LLC 0.86% 1,304,609 -16% 0.02% $19,516,950
KENNEDY CAPITAL MANAGEMENT LLC 0.84% 1,273,646 -1.9% 0.42% $19,053,744
VICTORY CAPITAL MANAGEMENT INC 0.82% 1,246,573 -27% 0.01% $18,648,732
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.82% 1,239,625 -15% 0.01% $18,544,790

Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 273,359 $4,437,487 +$84,371 $16.24 11
2025 Q3 145,445,972 $2,175,466,292 -$14,778,534 $14.96 268
2025 Q2 148,178,882 $1,726,248,551 -$46,396,273 $11.65 240
2025 Q1 152,930,142 $1,136,093,247 +$68,698,942 $7.43 222
2024 Q4 143,282,424 $858,588,192 +$3,881,916 $6.00 204
2024 Q3 143,105,692 $732,467,776 -$27,674,373 $5.12 184
2024 Q2 148,655,164 $538,029,201 +$26,127,842 $3.62 173
2024 Q1 142,447,362 $456,622,976 -$10,170,998 $3.21 186
2023 Q4 143,639,172 $703,966,709 +$9,702,761 $4.90 194
2023 Q3 140,492,459 $765,707,625 +$15,429,772 $5.45 187
2023 Q2 137,082,822 $919,786,637 +$21,850,661 $6.71 208
2023 Q1 133,849,942 $1,179,397,231 +$14,000,370 $8.83 223
2022 Q4 132,787,161 $1,014,264,343 +$14,824,828 $7.64 216
2022 Q3 131,007,037 $931,519,109 -$31,344,186 $7.12 205
2022 Q2 134,391,278 $1,083,708,756 +$49,040,887 $8.09 196
2022 Q1 125,563,937 $1,741,620,797 -$42,426,089 $13.88 207
2021 Q4 123,444,543 $3,462,001,567 +$139,816,088 $28.06 208
2021 Q3 117,860,461 $4,003,739,752 -$434,478 $33.99 212
2021 Q2 117,427,979 $4,796,005,013 +$143,202,294 $40.86 226
2021 Q1 113,768,226 $4,579,995,207 -$122,834,155 $40.26 238
2020 Q4 114,044,316 $6,743,577,628 +$149,068,690 $59.13 244
2020 Q3 111,322,127 $5,410,179,736 +$503,359,137 $48.63 206
2020 Q2 101,046,823 $4,886,712,149 +$212,566,003 $48.38 192
2020 Q1 96,830,392 $2,689,585,555 +$284,953,611 $27.78 144
2019 Q4 86,210,177 $2,579,382,908 +$148,626,753 $29.92 129
2019 Q3 81,041,176 $2,492,319,624 +$38,889,817 $30.90 116
2019 Q2 78,228,081 $3,735,247,853 +$3,731,000,860 $48.30 110
2019 Q1 103,941 $4,247,000 $40.86 1
2016 Q4 0 $0 -$10,117 $16.24 0
2016 Q3 235 $10,117 +$10,117 $43.05 1